Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Caffeine-modified electroconvulsive therapy in depressed patients with medical illness.

Lurie SN, Coffey CE.

J Clin Psychiatry. 1990 Apr;51(4):154-7.

PMID:
2324078
2.

Use of caffeine to lengthen seizures in ECT.

Hinkle PE, Coffey CE, Weiner RD, Cress M, Christison C.

Am J Psychiatry. 1987 Sep;144(9):1143-8.

PMID:
3631312
3.

Caffeine augmentation of ECT.

Coffey CE, Figiel GS, Weiner RD, Saunders WB.

Am J Psychiatry. 1990 May;147(5):579-85.

PMID:
2183632
4.

Augmentation of ECT seizures with caffeine.

Coffey CE, Weiner RD, Hinkle PE, Cress M, Daughtry G, Wilson WH.

Biol Psychiatry. 1987 May;22(5):637-49. No abstract available. Erratum in: Biol Psychiatry 1987 Oct;22(10):1299.

PMID:
3580438
5.

Aminophylline increases seizure length during electroconvulsive therapy.

Stern L, Dannon PN, Hirschmann S, Schriber S, Amytal D, Dolberg OT, Grunhaus L.

J ECT. 1999 Dec;15(4):252-7.

PMID:
10614031
6.
7.

Facilitation of ECT by intravenous administration of theophylline.

Leentjens AF, van den Broek WW, Kusuma A, Bruijn JA.

Convuls Ther. 1996 Dec;12(4):232-7.

PMID:
9034698
8.
9.

Etomidate anesthesia increases seizure duration during ECT. A retrospective study.

Trzepacz PT, Weniger FC, Greenhouse J.

Gen Hosp Psychiatry. 1993 Mar;15(2):115-20.

PMID:
8472938
10.

Relationship of seizure duration to antidepressant efficacy in electroconvulsive therapy.

Kales H, Raz J, Tandon R, Maixner D, DeQuardo J, Miller A, Becks L.

Psychol Med. 1997 Nov;27(6):1373-80.

PMID:
9403909
11.

Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold.

Shapira B, Lidsky D, Gorfine M, Lerer B.

J Clin Psychiatry. 1996 Jan;57(1):32-8.

PMID:
8543545
12.

Facilitation of ECT by caffeine pretreatment.

Shapira B, Lerer B, Gilboa D, Drexler H, Kugelmass S, Calev A.

Am J Psychiatry. 1987 Sep;144(9):1199-202.

PMID:
3631318
13.

A reappraisal of the role of caffeine in ECT.

McCall WV, Reid S, Rosenquist P, Foreman A, Kiesow-Webb N.

Am J Psychiatry. 1993 Oct;150(10):1543-5.

PMID:
8379563
14.

Ictal EEG regularity declines during a course of RUL ECT.

McCall WV, Colenda CC, Farah BA.

Convuls Ther. 1996 Dec;12(4):213-6.

PMID:
9034695
15.

Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine.

Beale MD, Pritchett JT, Kellner CH.

Convuls Ther. 1994 Sep;10(3):228-31.

PMID:
7834261
16.

Safety and efficacy of caffeine-augmented ECT in elderly depressives: a retrospective study.

Kelsey MC, Grossberg GT.

J Geriatr Psychiatry Neurol. 1995 Jul;8(3):168-72.

PMID:
7576041
17.

Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT.

Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M.

Biol Psychiatry. 1995 Jun 1;37(11):777-88.

PMID:
7647162
18.

Effects of caffeine pretreatment on measures of seizure impact.

Rosenquist PB, McCall WV, Farah A, Reboussin DM.

Convuls Ther. 1994 Jun;10(2):181-5.

PMID:
8069645
19.

Electroconvulsive therapy and major depression in Down's syndrome.

Lazarus A, Jaffe RL, Dubin WR.

J Clin Psychiatry. 1990 Oct;51(10):422-5.

PMID:
2145265
20.

Oral versus intravenous caffeine augmentation of ECT.

Jaffe R, Dubin WR.

Am J Psychiatry. 1992 Nov;149(11):1610. No abstract available.

PMID:
1285792

Supplemental Content

Support Center